Helicobacter Pylori Eradication Study

NCT03130452 PHASE4 COMPLETED

The purpose of this study was to evaluate the efficacy and compliance of tailored therapy which using the polymerase chain reaction for point mutation of clarithromycin, compared to concomitant therapy, in patients without history of H. pylori eradication.

Details

Lead sponsor	Inje University
Phase	PHASE4
Status	COMPLETED
Enrolment	423
Start date	Sat Dec 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Helicobacter Pylori Infection

Interventions

• Lansoprazole 30mg
• Amoxicillin 1.0g Tab
• Clarithromycin 500mg
• Metronidazole 500 mg

Countries

South Korea